{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:36:59Z","timestamp":1791239819718,"version":"4.1.0"},"reference-count":84,"publisher":"Frontline Medical Communications, Inc.","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.sder.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T07:12:44Z","timestamp":1221030764000},"page":"188-196","source":"Crossref","is-referenced-by-count":83,"title":["Hormonal Therapy for Acne"],"prefix":"10.12788","volume":"27","author":[{"given":"Rosalyn","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2133.1997.tb08748.x","article-title":"Post-adolescent acne: Review of clinical features","volume":"136","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2133.1997.tb14889.x","article-title":"Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis","volume":"136","author":"Thiboutot","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/archderm.140.4.423","article-title":"Quantitative documentation of a premenstrual flare of facial acne in adult women","volume":"140","author":"Lucky","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archderm.135.9.1041","article-title":"Androgen metabolism in sebaceous glands from subjects with and without acne","volume":"135","author":"Thiboutot","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/archderm.1992.01680200055006","article-title":"Sebaceous gland activity and serum dehydroepiandosterone sulfate levels in boys and girls","volume":"128","author":"Stewart","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1001\/archderm.130.3.308","article-title":"Acne vulgaris in premenarchal girls","volume":"130","author":"Lucky","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jc.76.2.524","article-title":"The androgen control of sebum production: Studies on subjects with dihydrotestosterone deficiency and complete androgen insensitivity","volume":"76","author":"Imperato-McGinley","year":"1993","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.sder.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1330467","article-title":"Localization of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands","volume":"133","author":"Choudhry","year":"1992","journal-title":"J Endocrinol"},{"key":"10.1016\/j.sder.2008.06.002_bib11","unstructured":"Liang T, Hoyer S, Yu R, et al: Immunocytochemical localization of androgen receptors in human skin using monoclonal antibodies against the androgen receptor. J Invest Dermatol 100663-100666, 199"},{"key":"10.1016\/j.sder.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12543363","article-title":"The relationship between the vitro activity of 3 beta-hydroxysteroid dehydrogenase delta 4-5-isomerase in human sebaceous glands and their secretory activity in vivo","volume":"81","author":"Simpton","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/1043-2760(93)90117-W","article-title":"The 3\u03b2-hydroxysteroid dehydrogenase gene family of enzymes","volume":"4","author":"Mason","year":"1993","journal-title":"Trends Endocrin Metab"},{"key":"10.1016\/j.sder.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1523-1747.1998.00322.x","article-title":"Oxidative activity of the type 2 isozyme of 17beta-hydroxysteroid dehydrogenase (17beta-HSD) predominates in human sebaceous glands","volume":"111","author":"Thiboutot","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1523-1747.ep12317162","article-title":"Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin","volume":"105","author":"Thiboutot","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.1964.03070220021004","article-title":"Effect of cyclic progestin-estrogen therapy on sebum and acne in women","volume":"190","author":"Strauss","year":"1964","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1016\/S0002-9343(99)80063-1","article-title":"Role of androgens in the developmental biology of the pilosebaceous unit","volume":"98","author":"Rosenfield","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.sder.2008.06.002_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000017861","article-title":"The human sebocyte culture model provides new insights into development and management of seborrhea and acne","volume":"196","author":"Zouboulis","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0092-8674(00)80467-5","article-title":"Exocrine gland dysfunction in MC5-R-deficient mice: Evidence for coordinated regulation of exocrine gland function by melanocortin peptides","volume":"91","author":"Chen","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.sder.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/en.139.5.2348","article-title":"Expression of melanocortin-5 receptor in secretory epithelia supports functional role in exocrine and endocrine glands","volume":"139","author":"van der Kraan","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.sder.2008.06.002_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1523-1747.2000.00094.x","article-title":"The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells","volume":"115","author":"Thiboutot","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.0022-202x.2001.01286.x","article-title":"Expression, candidate gene, and population studies of the melanocortin 5 receptor","volume":"116","author":"Hatta","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0968-0896(98)00260-0","article-title":"Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: Chemical synthesis, receptor binding affinities, and proliferative\/antiproliferative activities","volume":"7","author":"Tremblay","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.sder.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovarian syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.sder.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000211271","article-title":"Androgens affect the activity of human sebocytes in culture in a manner dependent on the localization of the sebaceous glands and their effect is antagonized by spironolactone","volume":"7","author":"Zouboulis","year":"1994","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.sder.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","article-title":"Update and future of hormonal therapy in acne","volume":"206","author":"Thiboutot","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","article-title":"Oral spironolactone improves acne vulgaris and reduces sebum excretion","volume":"111","author":"Goodfellow","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1985.tb02305.x","article-title":"Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia","volume":"112","author":"Burke","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","article-title":"Oral spironolactone: An effective treatment for acne vulgaris in women","volume":"115","author":"Muhlemann","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib30","first-page":"84","article-title":"Spironolactone and cimetidine in treatment of acne","volume":"68","author":"Hatwal","year":"1988","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","article-title":"Effects and side-effects of spironolactone therapy in women with acne","volume":"19","author":"Yemisci","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2008.06.002_bib33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archderm.134.9.1162-a","article-title":"Adverse effects of spironolactone therapy in women with acne","volume":"134","author":"Lubbos","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","article-title":"Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone","volume":"58","author":"Krunic","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0190-9622(91)70034-Y","article-title":"Spironolactone in dermatologic therapy","volume":"24","author":"Shaw","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000211481","article-title":"Activity and inhibition of 3-beta-ydroxysteroid dehydrogenase\/delta-5\u20134-isomerase in human skin","volume":"10","author":"T\u00f3th","year":"1997","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.sder.2008.06.002_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/1523-1747.ep12616131","article-title":"Characterization expression, and immunohistochemical localisation of 3\u03b2-hydroxysteroid dehydrogenase\/\u03945\u2013\u03944 isomerase in human skin","volume":"99","author":"Dumont","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1211357","article-title":"Experience in the long-term treatment of patients with hirsutism and\/or acne with cyproterone acetate containing preparations","volume":"103","author":"Van Waygen","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"suppl 4","key":"10.1016\/j.sder.2008.06.002_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10227-004-0754-8","article-title":"Hormonal treatment of acne: Review of current best evidence","volume":"8","author":"Tan","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.sder.2008.06.002_bib40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00455168","article-title":"Effect of cyproterone actetate-ethyinly estradiol treatment on the proportions of linoleic and sebaleic acids in various skin surface lipid classes","volume":"278","author":"Stewart","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.sder.2008.06.002_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000067821","article-title":"Update and future of systemic acne treatment","volume":"206","author":"Zouboulis","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.sder.2008.06.002_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2265.2002.01594.x","article-title":"Comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women","volume":"57","author":"Carmina","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"suppl 4","key":"10.1016\/j.sder.2008.06.002_bib43","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2008.06.002_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00016348609157049","article-title":"Cyproterone acetate vs levonorgestrel combined with ethinyl estradiol in the treatment of acne","volume":"134","author":"Carlborg","year":"1986","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.sder.2008.06.002_bib45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1345\/aph.10426","article-title":"Acute hepatitis induced by cyproterone acetate","volume":"35","author":"Giordano","year":"2001","journal-title":"Ann Pharmcother"},{"key":"10.1016\/j.sder.2008.06.002_bib46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humrep\/dem379","article-title":"Cyproterone acetate\/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy","volume":"23","author":"Franks","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.sder.2008.06.002_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00128071-200203080-00007","article-title":"Acne: Effect of hormones on pathogenesis and management","volume":"3","author":"Shaw","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0190-9622(90)70241-9","article-title":"Treatment of hirsutism with the pure anti-androgen flutamide","volume":"23","author":"Cusan","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib49","first-page":"423","article-title":"Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea","volume":"22","author":"Wang","year":"1999","journal-title":"Changgeng Yi Xue Za Zhi"},{"key":"10.1016\/j.sder.2008.06.002_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)56518-2","article-title":"Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial","volume":"61","author":"Cusan","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sder.2008.06.002_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/09513590009167658","article-title":"Treatment of hirsutism with lowest-dose flutamide (62.5 mg\/day)","volume":"14","author":"M\u00fcderris","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.sder.2008.06.002_bib52","first-page":"860","volume":"118","author":"Wysowski","year":"1993","journal-title":"Fatal and nonfatal hepatotoxicity associated with flutamide Ann Intern Med"},{"key":"10.1016\/j.sder.2008.06.002_bib53","first-page":"423","article-title":"Flutamide-induced hepatotoxicity: A report of a case series","volume":"93","author":"Garcia Cortes","year":"2001","journal-title":"Rev Enferm Dig"},{"key":"10.1016\/j.sder.2008.06.002_bib54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2265.1995.tb02922.x","article-title":"Clinical efficacy and safety of low dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism","volume":"43","author":"Dodin","year":"1995","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.sder.2008.06.002_bib55","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF03348907","article-title":"Treatment with a gonadotropin-releasing hormone agonist in acne or idiopathic hirsutism","volume":"16","author":"Faloia","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.sder.2008.06.002_bib56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2008.06.002_bib57","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1471-0528.1998.tb10235.x","article-title":"Risk of myocardial infarction, angina and stroke in users of oral contraceptives: An updated analysis of a cohort study","volume":"105","author":"Mant","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.sder.2008.06.002_bib58","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"suppl 11","key":"10.1016\/j.sder.2008.06.002_bib59","first-page":"975","article-title":"Evolution of progestins","volume":"47","author":"Thorneycroft","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.sder.2008.06.002_bib60","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.291.6504.1231","article-title":"Acne: Double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment","volume":"291","author":"Greenwood","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.sder.2008.06.002_bib61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1210\/jcem-71-1-8","article-title":"Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel","volume":"71","author":"Lemay","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.sder.2008.06.002_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib63","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.sder.2008.06.002_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sder.2008.06.002_bib65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1067\/mjd.2002.122192","article-title":"Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial","volume":"47","author":"Leyden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib66","first-page":"124","article-title":"Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","volume":"1","author":"Maloney","year":"2001","journal-title":"Clin J Womens Health"},{"key":"10.1016\/j.sder.2008.06.002_bib67","first-page":"932","article-title":"Clinical evaluation of a monophasic ethinylestradiol\/desogestrel-containing oral contraceptive","volume":"38","author":"Bilotta","year":"1988","journal-title":"Drug Res"},{"key":"10.1016\/j.sder.2008.06.002_bib68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.sder.2008.06.002_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13625180600983082","article-title":"Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome","volume":"12","author":"Pehlivanov","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.sder.2008.06.002_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.fertnstert.2006.11.137","article-title":"Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome","volume":"88","author":"De Leo","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sder.2008.06.002_bib71","unstructured":"Maloney JM, Kunz M, Lee-Sugh S, et al: Drosperinone 3mg\/ethinyl estradiol 20\u03bcg in the treatment of acne vulgaris: Lesion count, ISGA. Poster presented to the 55th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, May 5-9, 2007, San Diego, CA"},{"key":"10.1016\/j.sder.2008.06.002_bib72","first-page":"5","author":"Maloney","year":"2007","journal-title":"Drosperinone 3mg\/ethinyl estradiol 20\u03bcg in the treatment of acne vulgaris: investigator and subject self-assessment. Poster presented to the 55th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists, May"},{"key":"10.1016\/j.sder.2008.06.002_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: A randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.sder.2008.06.002_bib74","first-page":"84","article-title":"Occurrence of bleeding in women using combined hormonal contraceptives (ethinylestradiol 35 micrograms\/norgestimate 250 micrograms) in relation to regularity of administration and cycle start day","volume":"68","author":"Pasekova","year":"2003","journal-title":"Ceska Gynekol"},{"key":"10.1016\/j.sder.2008.06.002_bib75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(02)00326-8","article-title":"Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills","volume":"66","author":"Lara-Torre","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.sder.2008.06.002_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(02)00351-7","article-title":"Quick Start: A novel oral contraceptive initiation method","volume":"66","author":"Westhoff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.sder.2008.06.002_bib77","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0015-0282(02)04680-0","article-title":"Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial","volume":"79","author":"Westhoff","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.sder.2008.06.002_bib78","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,237 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2008.06.002_bib79","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/humupd\/dmh025","article-title":"Hormones and breast cancer","volume":"10","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.sder.2008.06.002_bib80","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interaction: A myth debunked","volume":"6","author":"Archer","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00009-8","article-title":"Interaction between broad spectrum antibiotics and the combined oral contraceptive pill","volume":"59","author":"Weaver","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.sder.2008.06.002_bib82","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(97)80322-2","article-title":"Oral contraceptive failure rates and oral antibiotics","volume":"36","author":"Helms","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archderm.1994.01690030128027","article-title":"Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives [letter]","volume":"130","author":"London","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2008.06.002_bib84","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0009-9236(98)90054-6","article-title":"A model for the turnover of dihydrotestosterone in the presence of the irreversible 5\u03b1-reductase inhibitors GI198745 and finasteride","volume":"64","author":"Gisleskog","year":"1998","journal-title":"Clin Pharmacol Ther"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562908000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562908000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/vol27_i3_Hormonal-Therapy.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T11:06:27Z","timestamp":1616151987000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1085562908000692"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2008.06.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1124422.581607","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1124422.618895","asserted-by":"object"}]},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}